Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Not Applicable
- Conditions
- Consecutive patients with coronary artery disease who were administered oral anticoagulant agent
- Registration Number
- JPRN-UMIN000017410
- Lead Sponsor
- Sendai Kousei Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 285
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who could not tolerate antiplatelet therapy or anticoagulation therapy 2. Patients who appeared to be inappropriate for this study, determined by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composite of major adverse events (death, acute coronary syndrome, stroke, any revascularization and systemic embolism), and hemorrhagic complication measured by BARC
- Secondary Outcome Measures
Name Time Method